Related Experiment Video
Updated: Apr 3, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Targeting the sensory-sympathetic axis for cancer immunotherapy
1Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou 730000, PR China.
Tumors exploit a vagal nerve circuit to suppress immune cells like macrophages and T cells. Blocking this neural pathway with beta-blockers could enhance antitumor immunity.
Area of Science:
- Neuroscience
- Immunology
- Oncology
Background:
- Tumor evasion of the immune system is a significant challenge in cancer therapy.
- The role of neural circuits in modulating antitumor immunity remains largely unexplored.
Purpose of the Study:
- To investigate how tumors manipulate neural circuits to suppress the immune response.
- To identify specific neural pathways and signaling mechanisms involved in immune evasion in lung adenocarcinoma.
Main Methods:
- Utilized a lung adenocarcinoma model to study neural-immune interactions.
- Investigated the vagal sensory-brain stem sympathetic circuit.
- Analyzed the role of beta2-adrenergic signaling in immune suppression.
Main Results:
- Identified a vagal sensory-brain stem sympathetic circuit that suppresses macrophages and CD8+ T cells.
- Demonstrated that beta2-adrenergic signaling mediates this immune suppression.
- Showed that disrupting this neural axis restores antitumor immunity.
Conclusions:
- Tumors can hijack neural circuits to evade immune surveillance.
- Targeting the identified neural axis, potentially with beta-blockers, offers a novel therapeutic strategy.
- Neural modulation presents a promising avenue for enhancing cancer immunotherapy.
More Related Videos
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
The Tumor Microenvironment
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...